Drug Discovery

The landscape of modern medicine is currently navigating a tectonic shift as the long-standing reliance on personal willpower for weight management is being replaced by a sophisticated neurobiological understanding of metabolic health. For more than sixty years, the prevailing clinical and social

For decades, the medical community has sought a silver bullet for oncology, yet the most profound breakthrough lies not in a single miracle drug but in the orchestration of complex, individualized therapeutic combinations tailored to a patient’s specific molecular signature. The traditional

Hidden within the crushing depths of the Mariana Trench and the frozen veins of ancient glaciers lies a biological arsenal that could decide the future of human survival against the rising tide of drug-resistant bacteria. While the world’s most advanced laboratories struggle to engineer new cures,

The landscape of therapeutic discovery is undergoing a seismic shift as artificial intelligence moves from being a mere digital assistant to becoming the very architecture upon which modern biology is built. Anthropic has recently solidified this transition by announcing the acquisition of

The biological resilience of pancreatic ductal adenocarcinoma (PDAC) has long earned it a reputation as the "impenetrable fortress" of oncology, maintaining a lethal grip on patients despite decades of intensive global research. While the discovery of ferroptosis—a specialized, iron-dependent form

Ivan Kairatov is a leading biopharma expert with an extensive background in research and development, specializing in the intersection of biotechnology and advanced computational innovation. With a career dedicated to unraveling the complexities of the human genome and neurodegenerative